샘플 요청 목록

 카트 문의
시장보고서
상품코드
1785844

세계의 바이오닉 아이즈 시장

Bionic Eyes
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 286 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 바이오닉 아이즈 시장은 2030년까지 6억 5,710만 달러에 이를 전망

2024년에 3억 2,720만 달러로 추정되는 바이오닉 아이즈 세계 시장은 2024-2030년간 CAGR 12.3%로 성장하여 2030년에는 6억 5,710만 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 외안부는 CAGR 11.5%를 나타내고, 분석 기간 종료시에는 4억 2,290만 달러에 이를 것으로 예측됩니다. Implanted Eye 부문의 성장률은 분석 기간중 CAGR 13.9%로 추정됩니다.

미국 시장은 8,910만 달러로 추정, 중국은 CAGR16.4%로 성장 예측

미국의 바이오닉 아이즈 시장은 2024년에는 8,910만 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 1억 3,690만 달러 규모에 이를 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 16.4%로 추정됩니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 9.1%와 10.9%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 약 9.7%를 보일 전망입니다.

세계의 바이오닉 아이즈 시장 - 주요 동향과 촉진요인 정리

기술 혁신이 바이오닉 아이즈 시장을 어떻게 재정의하고 있는가?

바이오닉 아이즈 분야는 신경보철, 인공지능, 바이오 일렉트로닉스의 최첨단 기술을 통해 급속한 발전을 거듭하고 있습니다. 과학자들과 연구자들은 고해상도 망막 이식, 광유전학에 기반한 시력 회복, 무선 시각 보철을 개발하여 바이오닉 아이즈의 기능을 크게 향상시키고 있습니다. AI 기반 이미지 처리의 통합을 통해 이러한 임플란트는 시각 데이터를 보다 효과적으로 해석하여 사용자에게 보다 선명하고 적응력이 높은 시각 기능을 제공할 수 있습니다. 부품의 소형화와 생체 적합성 재료의 사용으로 임플란트의 수명과 편안함이 향상되어, 바이오닉 아이즈는 퇴행성 안질환을 앓고 있는 사람들에게 장기적으로 실행 가능한 솔루션이 될 수 있습니다. 또한, 뇌-컴퓨터 인터페이스(BCI) 기술의 발달로 시각 영역을 직접 자극할 수 있는 길이 열리고 있으며, 시신경이 손상된 경우에도 시력을 회복할 수 있는 가능성이 있습니다. 연구가 진행됨에 따라 업계는 기존의 카메라 기반 임플란트에서 실시간 환경 적응이 가능한 보다 진보된 솔루션으로의 전환을 목격하고 있으며, 시력 회복에 변화를 가져올 수 있는 무대가 마련되고 있습니다.

바이오닉 아이즈에 대한 수요가 인구통계학적으로 증가하는 이유는 무엇일까?

세계적으로 시각 장애의 유병률이 증가하고 있는 것은 바이오닉 아이즈에 대한 수요를 촉진하는 중요한 요인이 되고 있습니다. 세계보건기구(WHO)에 따르면, 2억 8,500만 명 이상의 사람들이 시력 저하로 고통받고 있으며, 노화성 황반변성(AMD), 당뇨망막병증, 망막색소변성증이 큰 비중을 차지하고 있습니다. 세계 인구의 고령화, 특히 선진국에서는 첨단 시력 회복 솔루션에 대한 필요성이 높아지면서 바이오닉 안구 임플란트의 채택이 확대되고 있습니다. 이와 함께 당뇨병으로 인한 시력저하와 선천성 안질환 사례가 증가하고 있는 것도 시장 범위를 더욱 확대시키고 있습니다. 또한, 시력 회복 장치에 대한 접근성 향상을 위한 정부의 이니셔티브와 헬스케어 정책에 힘입어 보조 의료 기술에 대한 인식과 수용도가 높아진 것도 이 수요에 기여하는 요인 중 하나입니다. 안과 연구에 대한 투자 증가와 의료비 증가에 따라 바이오닉 아이즈 솔루션은 실험적인 제품에서 점차 실용화 가능한 제품으로 전환되고 있으며, 전 세계 수백만 명의 시각 장애인의 삶을 변화시킬 수 있는 혜택을 기대할 수 있습니다.

주요 산업 기업와 전략적 투자는 어떻게 시장을 형성하고 있는가?

경쟁 환경은 연구개발(R&:D), 전략적 파트너십, 공동 혁신에 중점을 두고 있는 것이 특징입니다. Second Sight Medical Products, Pixium Vision, Bionic Vision Technologies 등 주요 기업들은 차세대 시각 보조기구 개발의 최전선에 서 있습니다. 나노 기술, 무선 전력 전송, 클라우드 기반 데이터 처리를 바이오닉 아이즈 시스템에 통합함으로써 장비의 효율성이 향상되고, 시장 확대의 새로운 기회가 확대되고 있습니다. 또한, 의료 기관, 하이테크 기업, 대학 간의 협력은 기술 혁신의 속도를 가속화하여 보다 정교한 바이오닉 아이즈 솔루션의 상용화를 촉진하고 있습니다. 규제 프레임워크가 진화함에 따라 기업들은 미국 FDA, 유럽의약품청(EMA) 등 규제기관의 승인을 받기 위해 임상시험에 많은 투자를 하고 있습니다. 벤처 캐피탈 기업과 정부 자금이 연구 이니셔티브를 강화함에 따라 업계는 점점 더 효과적이고 널리 이용 가능한 시력 회복 솔루션을 제공하는 궤도에 오르고 있습니다. 또한, 헬스케어 분야에서 AI와 로봇공학의 영향력이 커지면서 환자 경험을 재정의하고 바이오닉아이 기술의 폭넓은 수용과 채택을 촉진할 것으로 예측됩니다.

바이오닉 아이즈 시장의 성장을 가속화하는 주요 촉진요인은 무엇인가?

바이오닉 아이즈 시장의 성장은 기술 발전, 시력 관련 질환의 유병률 증가, 안과 분야에서의 적용 확대 등 여러 요인에 의해 주도되고 있습니다. 생체공학 망막 이식, 광전자 장치, 신경 인터페이스의 획기적인 발전으로 바이오닉 아이즈의 효능이 크게 향상되어 시력 회복을 위한 유력한 선택이 되고 있습니다. 고령화 사회와 더불어 전 세계적으로 안질환의 부담이 증가함에 따라 첨단 치료 옵션에 대한 수요가 증가하고 있으며, 바이오닉 아이즈 기술은 시각 장애에 대한 중요한 솔루션으로 자리매김하고 있습니다. 또한, 정부 보조금과 보험 적용으로 이식형 의료기기의 가격이 저렴해져 선진국과 신흥 경제국 모두에서 쉽게 이용할 수 있게 되었습니다. 소비자 행동도 진화하고 있으며, 웨어러블 및 임베디드 보조 기술에 대한 수용이 확대되면서 시장 트렌드가 재편되고 있습니다. 또한, AI 기반 시각 강화 도구와 증강현실(AR) 통합에 대한 전략적 투자는 중증 시력 상실 환자들에게 새로운 가능성을 제시하며 시장을 선도하고 있습니다. 업계가 환자 중심의 혁신으로 나아가고 있는 가운데, 생명공학, 디지털 헬스, 정밀의료의 융합은 전 세계적으로 바이오닉 아이즈의 채택을 가속화할 것입니다.

부문

제품 유형(외안부, 이식형 안구);최종사용자(병원 최종사용자, 외래시설 최종사용자, 연구 및 제조 최종사용자)

조사 대상 기업 예

  • Bionic Vision Technologies
  • CorneaGen
  • Cortigent, Inc.
  • Geuder AG
  • Iridium Medical Technology Co., Ltd
  • Labtician Ophthalmics, Inc.
  • LambdaVision, Inc.
  • Nanochap Electronics Co., Ltd
  • Neostrata Co., Inc.
  • Optobionics
  • Science Corporation
  • Zyvex Labs, LLC

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI툴에 의해서, 시장과 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 25.08.14

Global Bionic Eyes Market to Reach US$657.1 Million by 2030

The global market for Bionic Eyes estimated at US$327.2 Million in the year 2024, is expected to reach US$657.1 Million by 2030, growing at a CAGR of 12.3% over the analysis period 2024-2030. External Eye, one of the segments analyzed in the report, is expected to record a 11.5% CAGR and reach US$422.9 Million by the end of the analysis period. Growth in the Implanted Eye segment is estimated at 13.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$89.1 Million While China is Forecast to Grow at 16.4% CAGR

The Bionic Eyes market in the U.S. is estimated at US$89.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$136.9 Million by the year 2030 trailing a CAGR of 16.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.1% and 10.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.7% CAGR.

Global Bionic Eyes Market - Key Trends & Drivers Summarized

How Are Technological Breakthroughs Redefining the Bionic Eyes Market?

The field of bionic eyes is experiencing rapid advancements driven by cutting-edge technologies in neuroprosthetics, artificial intelligence, and bioelectronics. Scientists and researchers are developing high-resolution retinal implants, optogenetics-based vision restoration, and wireless visual prosthetics, significantly enhancing the functionality of bionic eyes. The integration of AI-powered image processing allows these implants to interpret visual data more effectively, providing users with sharper, clearer, and more adaptive vision capabilities. Miniaturization of components and the use of biocompatible materials have improved implant longevity and comfort, making bionic eyes a viable long-term solution for individuals suffering from degenerative eye conditions. Moreover, developments in brain-computer interface (BCI) technology are paving the way for direct visual cortex stimulation, which has the potential to restore vision even in cases where optic nerve damage has occurred. As research progresses, the industry is witnessing a shift from traditional camera-based implants to more advanced solutions capable of real-time environmental adaptation, setting the stage for a transformative impact in vision restoration.

Why Is the Demand for Bionic Eyes Rising Across Demographics?

The increasing prevalence of visual impairments worldwide is a crucial factor driving the demand for bionic eyes. According to the World Health Organization (WHO), over 285 million people suffer from vision loss, with a significant proportion affected by age-related macular degeneration (AMD), diabetic retinopathy, and retinitis pigmentosa. The aging global population, particularly in developed nations, has fueled the need for advanced vision restoration solutions, leading to greater adoption of bionic eye implants. In parallel, rising cases of diabetes-induced vision loss and congenital eye disorders have further expanded the market scope. Another factor contributing to this demand is the growing awareness and acceptance of assistive medical technologies, supported by government initiatives and healthcare policies aimed at improving accessibility to vision restoration devices. With increased investments in ophthalmology research and higher healthcare expenditure, bionic eye solutions are gradually transitioning from experimental to commercially viable products, promising life-changing benefits for millions of visually impaired individuals worldwide.

How Are Key Industry Players and Strategic Investments Shaping the Market?

The competitive landscape of the bionic eyes market is marked by a strong emphasis on research and development (R&D), strategic partnerships, and collaborative innovations. Leading companies such as Second Sight Medical Products, Pixium Vision, and Bionic Vision Technologies are at the forefront of developing next-generation visual prosthetics. The integration of nanotechnology, wireless power transmission, and cloud-based data processing in bionic eye systems has enhanced device efficiency, opening new opportunities for market expansion. Additionally, collaboration between medical institutions, tech firms, and universities has accelerated the pace of innovation, leading to the commercialization of more sophisticated bionic eye solutions. As regulatory frameworks evolve, companies are investing heavily in clinical trials to secure approvals from regulatory bodies such as the U.S. FDA and the European Medicines Agency (EMA). With venture capital firms and government funding bolstering research initiatives, the industry is on track to deliver increasingly effective and widely accessible vision restoration solutions. Moreover, the growing influence of AI and robotics in the healthcare sector is expected to redefine patient experiences, driving broader acceptance and adoption of bionic eye technology.

What Are the Key Drivers Accelerating the Growth of the Bionic Eyes Market?

The growth in the bionic eyes market is driven by several factors, including technological advancements, increasing prevalence of vision-related disorders, and expanding applications in ophthalmology. Breakthroughs in bioengineered retinal implants, optoelectronic devices, and neural interfacing have significantly improved the efficacy of bionic eyes, making them a compelling option for vision restoration. The rising global burden of eye diseases, coupled with the aging population, has intensified demand for advanced treatment options, positioning bionic eye technology as a crucial solution for visual impairments. Additionally, the increasing affordability of implantable medical devices, aided by government subsidies and insurance coverage, has facilitated greater accessibility in both developed and emerging economies. Consumer behavior is also evolving, with growing acceptance of wearable and implantable assistive technologies reshaping market trends. Furthermore, strategic investments in AI-driven visual enhancement tools and augmented reality (AR) integration are propelling the market forward, offering new possibilities for patients with severe vision loss. As the industry moves toward more patient-centric innovations, the convergence of biotechnology, digital health, and precision medicine will continue to accelerate the adoption of bionic eyes on a global scale.

SCOPE OF STUDY:

The report analyzes the Bionic Eyes market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (External Eye, Implanted Eye); End-Use (Hospitals End-Use, Outpatient Facilities End-Use, Research & Manufacturing End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 52 Featured) -

  • Bionic Vision Technologies
  • CorneaGen
  • Cortigent, Inc.
  • Geuder AG
  • Iridium Medical Technology Co., Ltd
  • Labtician Ophthalmics, Inc.
  • LambdaVision, Inc.
  • Nanochap Electronics Co., Ltd
  • Neostrata Co., Inc.
  • Optobionics
  • Science Corporation
  • Zyvex Labs, LLC

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Bionic Eyes - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Incidence of Retinal Degenerative Diseases Drives Demand for Bionic Eye Solutions
    • Expansion of Vision Restoration Research Throws the Spotlight on Retinal Implant and Neurovisual Interfaces
    • OEM Focus on Artificial Photoreceptors and Retinal Microelectrode Arrays Spurs Development of Visual Prosthetics
    • Growth in Cortical Visual Prosthesis Programs Expands Access to Non-Retina-Dependent Bionic Eye Models
    • Regulatory Progress in Human Trials and Compassionate Use Exemptions Supports Market Readiness
    • Advancements in AI-Powered Image Processing Enhance Real-Time Visual Perception and Navigation
    • Partnerships Between Ophthalmology Institutions and Neurotech Firms Accelerate Clinical Validation Pipelines
    • Increased Use of Augmented Reality and Depth Mapping Fuels Smart Navigation Integration in Bionic Eyes
    • Growth in Wearable Vision Enhancement Devices Supports Gradual Transition Toward Fully Implanted Systems
    • OEM Innovation in Wireless Power and Minimally Invasive Implantation Techniques Enhances Surgical Adoption
    • Public and Private Investment in Blindness Reversal Technologies Expands Bionic Eye R&D Funding
    • Use of Bionic Eyes in Visual Training and Rehabilitation Centers Promotes Post-Implant Therapy Continuity
    • Integration With Companion Apps and Cloud-Based Vision Analytics Enhances Functional Feedback Loops
    • Emerging Use in Color Blindness Correction and Visual Contrast Enhancement Expands Non-Therapeutic Applications
    • Rising Demand for Visual Independence Among the Elderly Strengthens Business Case for Vision Restoration
    • Global Increase in Retinitis Pigmentosa and AMD Cases Propels Growth in Retinal Prosthesis Segment
    • OEM Collaboration With AI Vision Algorithms and Machine Learning Models Enables Adaptive Vision Processing
    • Challenges in Electrode-Tissue Biocompatibility Drive Innovation in Coatings and Materials Science
    • Regulatory Pathway Harmonization Across Markets Encourages Cross-Border Clinical Trials and Adoption
    • Long-Term Safety Data and Real-World Case Studies Strengthen Physician and Patient Confidence in Bionic Eye Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Bionic Eyes Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Bionic Eyes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Bionic Eyes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Bionic Eyes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for External Eye by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for External Eye by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for External Eye by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Implanted Eye by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Implanted Eye by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Implanted Eye by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Outpatient Facilities End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Outpatient Facilities End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Outpatient Facilities End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Research & Manufacturing End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Research & Manufacturing End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Research & Manufacturing End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Bionic Eyes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Bionic Eyes by Product Type - External Eye and Implanted Eye - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Bionic Eyes by Product Type - External Eye and Implanted Eye Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Bionic Eyes by Product Type - Percentage Breakdown of Value Sales for External Eye and Implanted Eye for the Years 2015, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Bionic Eyes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Bionic Eyes by Product Type - External Eye and Implanted Eye - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Bionic Eyes by Product Type - External Eye and Implanted Eye Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Bionic Eyes by Product Type - Percentage Breakdown of Value Sales for External Eye and Implanted Eye for the Years 2015, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Bionic Eyes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2015, 2025 & 2030
  • JAPAN
    • Bionic Eyes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Bionic Eyes by Product Type - External Eye and Implanted Eye - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Bionic Eyes by Product Type - External Eye and Implanted Eye Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Bionic Eyes by Product Type - Percentage Breakdown of Value Sales for External Eye and Implanted Eye for the Years 2015, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Bionic Eyes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2015, 2025 & 2030
  • CHINA
    • Bionic Eyes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Bionic Eyes by Product Type - External Eye and Implanted Eye - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Bionic Eyes by Product Type - External Eye and Implanted Eye Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Bionic Eyes by Product Type - Percentage Breakdown of Value Sales for External Eye and Implanted Eye for the Years 2015, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Bionic Eyes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2015, 2025 & 2030
  • EUROPE
    • Bionic Eyes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Bionic Eyes by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Bionic Eyes by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Bionic Eyes by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Bionic Eyes by Product Type - External Eye and Implanted Eye - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Bionic Eyes by Product Type - External Eye and Implanted Eye Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Bionic Eyes by Product Type - Percentage Breakdown of Value Sales for External Eye and Implanted Eye for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Bionic Eyes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2015, 2025 & 2030
  • FRANCE
    • Bionic Eyes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Bionic Eyes by Product Type - External Eye and Implanted Eye - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Bionic Eyes by Product Type - External Eye and Implanted Eye Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Bionic Eyes by Product Type - Percentage Breakdown of Value Sales for External Eye and Implanted Eye for the Years 2015, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Bionic Eyes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2015, 2025 & 2030
  • GERMANY
    • Bionic Eyes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Bionic Eyes by Product Type - External Eye and Implanted Eye - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Bionic Eyes by Product Type - External Eye and Implanted Eye Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Bionic Eyes by Product Type - Percentage Breakdown of Value Sales for External Eye and Implanted Eye for the Years 2015, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Bionic Eyes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Bionic Eyes by Product Type - External Eye and Implanted Eye - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Bionic Eyes by Product Type - External Eye and Implanted Eye Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Bionic Eyes by Product Type - Percentage Breakdown of Value Sales for External Eye and Implanted Eye for the Years 2015, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Bionic Eyes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Bionic Eyes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Bionic Eyes by Product Type - External Eye and Implanted Eye - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Bionic Eyes by Product Type - External Eye and Implanted Eye Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Bionic Eyes by Product Type - Percentage Breakdown of Value Sales for External Eye and Implanted Eye for the Years 2015, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Bionic Eyes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Bionic Eyes by Product Type - External Eye and Implanted Eye - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Bionic Eyes by Product Type - External Eye and Implanted Eye Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Spain 15-Year Perspective for Bionic Eyes by Product Type - Percentage Breakdown of Value Sales for External Eye and Implanted Eye for the Years 2015, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Bionic Eyes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Bionic Eyes by Product Type - External Eye and Implanted Eye - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Bionic Eyes by Product Type - External Eye and Implanted Eye Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Russia 15-Year Perspective for Bionic Eyes by Product Type - Percentage Breakdown of Value Sales for External Eye and Implanted Eye for the Years 2015, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Bionic Eyes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Bionic Eyes by Product Type - External Eye and Implanted Eye - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Bionic Eyes by Product Type - External Eye and Implanted Eye Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Bionic Eyes by Product Type - Percentage Breakdown of Value Sales for External Eye and Implanted Eye for the Years 2015, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Bionic Eyes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Bionic Eyes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Bionic Eyes by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Bionic Eyes by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Bionic Eyes by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Bionic Eyes by Product Type - External Eye and Implanted Eye - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Bionic Eyes by Product Type - External Eye and Implanted Eye Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Bionic Eyes by Product Type - Percentage Breakdown of Value Sales for External Eye and Implanted Eye for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Bionic Eyes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Bionic Eyes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Bionic Eyes by Product Type - External Eye and Implanted Eye - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Bionic Eyes by Product Type - External Eye and Implanted Eye Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Australia 15-Year Perspective for Bionic Eyes by Product Type - Percentage Breakdown of Value Sales for External Eye and Implanted Eye for the Years 2015, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Bionic Eyes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2015, 2025 & 2030
  • INDIA
    • Bionic Eyes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Bionic Eyes by Product Type - External Eye and Implanted Eye - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Bionic Eyes by Product Type - External Eye and Implanted Eye Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: India 15-Year Perspective for Bionic Eyes by Product Type - Percentage Breakdown of Value Sales for External Eye and Implanted Eye for the Years 2015, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Bionic Eyes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Bionic Eyes by Product Type - External Eye and Implanted Eye - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Bionic Eyes by Product Type - External Eye and Implanted Eye Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: South Korea 15-Year Perspective for Bionic Eyes by Product Type - Percentage Breakdown of Value Sales for External Eye and Implanted Eye for the Years 2015, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Bionic Eyes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bionic Eyes by Product Type - External Eye and Implanted Eye - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Bionic Eyes by Product Type - External Eye and Implanted Eye Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 15-Year Perspective for Bionic Eyes by Product Type - Percentage Breakdown of Value Sales for External Eye and Implanted Eye for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Bionic Eyes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Bionic Eyes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Bionic Eyes by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Bionic Eyes by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Latin America 15-Year Perspective for Bionic Eyes by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Bionic Eyes by Product Type - External Eye and Implanted Eye - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Bionic Eyes by Product Type - External Eye and Implanted Eye Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Bionic Eyes by Product Type - Percentage Breakdown of Value Sales for External Eye and Implanted Eye for the Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Bionic Eyes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Bionic Eyes by Product Type - External Eye and Implanted Eye - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Bionic Eyes by Product Type - External Eye and Implanted Eye Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Argentina 15-Year Perspective for Bionic Eyes by Product Type - Percentage Breakdown of Value Sales for External Eye and Implanted Eye for the Years 2015, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Bionic Eyes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Bionic Eyes by Product Type - External Eye and Implanted Eye - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Bionic Eyes by Product Type - External Eye and Implanted Eye Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Brazil 15-Year Perspective for Bionic Eyes by Product Type - Percentage Breakdown of Value Sales for External Eye and Implanted Eye for the Years 2015, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Bionic Eyes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Bionic Eyes by Product Type - External Eye and Implanted Eye - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Bionic Eyes by Product Type - External Eye and Implanted Eye Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Mexico 15-Year Perspective for Bionic Eyes by Product Type - Percentage Breakdown of Value Sales for External Eye and Implanted Eye for the Years 2015, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Bionic Eyes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Bionic Eyes by Product Type - External Eye and Implanted Eye - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Bionic Eyes by Product Type - External Eye and Implanted Eye Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 15-Year Perspective for Bionic Eyes by Product Type - Percentage Breakdown of Value Sales for External Eye and Implanted Eye for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Bionic Eyes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Bionic Eyes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Bionic Eyes by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Bionic Eyes by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Middle East 15-Year Perspective for Bionic Eyes by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Bionic Eyes by Product Type - External Eye and Implanted Eye - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Bionic Eyes by Product Type - External Eye and Implanted Eye Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Bionic Eyes by Product Type - Percentage Breakdown of Value Sales for External Eye and Implanted Eye for the Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Bionic Eyes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Bionic Eyes by Product Type - External Eye and Implanted Eye - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Bionic Eyes by Product Type - External Eye and Implanted Eye Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Iran 15-Year Perspective for Bionic Eyes by Product Type - Percentage Breakdown of Value Sales for External Eye and Implanted Eye for the Years 2015, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Bionic Eyes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Bionic Eyes by Product Type - External Eye and Implanted Eye - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Bionic Eyes by Product Type - External Eye and Implanted Eye Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Israel 15-Year Perspective for Bionic Eyes by Product Type - Percentage Breakdown of Value Sales for External Eye and Implanted Eye for the Years 2015, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Bionic Eyes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Bionic Eyes by Product Type - External Eye and Implanted Eye - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Bionic Eyes by Product Type - External Eye and Implanted Eye Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 15-Year Perspective for Bionic Eyes by Product Type - Percentage Breakdown of Value Sales for External Eye and Implanted Eye for the Years 2015, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Bionic Eyes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Bionic Eyes by Product Type - External Eye and Implanted Eye - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Bionic Eyes by Product Type - External Eye and Implanted Eye Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: UAE 15-Year Perspective for Bionic Eyes by Product Type - Percentage Breakdown of Value Sales for External Eye and Implanted Eye for the Years 2015, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Bionic Eyes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Bionic Eyes by Product Type - External Eye and Implanted Eye - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Bionic Eyes by Product Type - External Eye and Implanted Eye Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 15-Year Perspective for Bionic Eyes by Product Type - Percentage Breakdown of Value Sales for External Eye and Implanted Eye for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Bionic Eyes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2015, 2025 & 2030
  • AFRICA
    • Bionic Eyes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Bionic Eyes by Product Type - External Eye and Implanted Eye - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Bionic Eyes by Product Type - External Eye and Implanted Eye Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Africa 15-Year Perspective for Bionic Eyes by Product Type - Percentage Breakdown of Value Sales for External Eye and Implanted Eye for the Years 2015, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Bionic Eyes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제